IP Library Assignment 061579/0838
Patent Assignment
Reel/Frame 061579/0838

Assignment of Assignor's Interest

Recorded: 2022-10-28 Pages: 5
Assignor
CELLULAR BIOMEDICINE GROUP HK LTD.
Executed: 2022-10-26
Assignee
SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
BUILDING 3, NO. 85 FALADI ROAD, PUDONG NEW DISTRICT, SHANGHAI, 201210, CHINA
Covered Property (1)
Method for Large-Scale Production of Lentivirus by Using Gmp-Level Serum-Free Suspension Cells
Application: 17/041,578 →
Publication: US 2021/0363497
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 6, 2020
From: HONG, YI; YAN, TING; YING, JIANGGUO; ZHANG, HAOJIE
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 053985/0904 →
Change of Name Apr 16, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067128/0044 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 67128 Frame: 44. Assignor(S) Hereby Confirms the Change of Name. May 7, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067334/0083 →